title: The effects of substance P and acetylcholine on human tenocyte proliferation converge mechanistically via TGF-β1.
abstract: Previous in vitro studies on human tendon cells (tenocytes) have demonstrated that the exogenous administration of substance P (SP) and acetylcholine (ACh) independently result in tenocyte proliferation, which is a prominent feature of tendinosis. Interestingly, the possible link between SP and ACh has not yet been explored in human tenocytes. Recent studies in other cell types demonstrate that both SP and ACh independently upregulate TGF-β1 expression via their respective receptors, the neurokinin 1 receptor (NK-1R) and muscarinic ACh receptors (mAChRs). Furthermore, TGF-β1 has been shown to downregulate NK-1R expression in human keratocytes. The aim of this study was to examine if TGF-β1 is the intermediary player involved in mediating the proliferative pathway shared by SP and ACh in human tenocytes. The results showed that exogenous administration of SP and ACh both caused significant upregulation of TGF-β1 at the mRNA and protein levels. Exposing cells to TGF-β1 resulted in increased cell viability of tenocytes, which was blocked in the presence of the TGFβRI/II kinase inhibitor. In addition, the proliferative effects of SP and ACh on tenocytes were reduced by the TGFβRI/II kinase inhibitor; this supports the hypothesis that the proliferative effects of these signal substances are mediated via the TGF-β axis. Furthermore, exogenous TGF-β1 downregulated NK-1R and mAChRs expression at both the mRNA and protein levels, and these effects were negated by simultaneous exposure to the TGFβRI/II kinase inhibitor, suggesting a negative feedback loop. In conclusion, the results indicate that TGF-β1 is the intermediary player through which the proliferative actions of both SP and ACh converge mechanistically.
authors.affiliation: Dept. of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden.|Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
authors.forename: Gloria
authors.initials: G
authors.lastname: Fong
authors.affiliation: Dept. of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden.
authors.forename: Ludvig J
authors.initials: LJ
authors.lastname: Backman
authors.affiliation: Dept. of Community Medicine and Rehabilitation, Sports Medicine, Umeå University, Umeå, Sweden.
authors.forename: Håkan
authors.initials: H
authors.lastname: Alfredson
authors.affiliation: Centre for Hip Health and Mobility, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
authors.forename: Alex
authors.initials: A
authors.lastname: Scott
authors.affiliation: Dept. of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden.|Dept. of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden.
authors.forename: Patrik
authors.initials: P
authors.lastname: Danielson
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D006801:Humans; D011976:Receptors, Muscarinic / Q000378:metabolism; D018040:Receptors, Neurokinin-1 / Q000378:metabolism; D013373:Substance P / Q000494:pharmacology*; D000070916:Tenocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D053773:Transforming Growth Factor beta1 / Q000502:physiology*
chemical_list: D011976:Receptors, Muscarinic; D018040:Receptors, Neurokinin-1; D053773:Transforming Growth Factor beta1; D013373:Substance P; D000109:Acetylcholine